Search results
Surmodics (SRDX) Rallies on FDA Approval for SurVeil DCB
Zacks via Yahoo Finance· 12 months agoSurmodics' (SRDX) SurVeil DCB is indicated to treat percutaneous transluminal angioplasty in...
Surmodics (SRDX) Stock Skids 32% on Negative Regulatory Update
Zacks via Yahoo Finance· 1 year agoShares of Surmodics, Inc. SRDX have declined 31.8% since the close on Jan 18, following...
After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval
Benzinga via Yahoo Finance· 12 months agoThe FDA has approved Surmodics Inc's (NASDAQ: SRDX) SurVeil drug-coated balloon (DCB), a...
Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCB
Zacks via Yahoo Finance· 1 year agoSurmodics, Inc. SRDX announced its receipt of positive formal feedback from the FDA regarding its...
Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoSurmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript November 10, 2023 Operator: Welcome...
Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View
Zacks via Yahoo Finance· 4 months agoSurmodics, Inc. SRDX delivered break-even adjusted earnings per share (EPS) in the first quarter of...
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
Benzinga via Yahoo Finance· 1 year agoSurmodics Inc (NASDAQ: SRDX) has received a letter from the FDA related to its premarket approval...
Why Is SurModics (SRDX) Up 21.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 week agoA month has gone by since the last earnings report for SurModics (SRDX). Shares have added about...
Surmodics Inc (SRDX) Reports Fiscal Year 2023 Earnings Growth and Introduces FY 2024 Guidance
GuruFocus.com via Yahoo Finance· 7 months agoSurmodics Inc (NASDAQ:SRDX) reports an 8% increase in Q4 FY 2023 total revenue, reaching $28.0...
Why Shares of Surmodics Jumped This Week
Motley Fool· 12 months agoWhat happened Shares of Surmodics (NASDAQ: SRDX) were up by 24.1% for the week as of Friday morning, according to data provided by S&P Global Market...
